www.Top100Medicine.com - TOP 100 MEDICAL SITES
TOP 100 MEDICAL SITES
 Main  |  Add a Site  |  FREE Content for Your Web-site  |  Bookmark this site  |  Webmaster 
Updated Sat, February 4, 2012.
501.www.pediatria.it2370
502.neuroscript.com2360
503.www.huidarts.com2350
504.www.stethosglobe.de2340
505.www.ospedaliriuniti.bergamo.it2340
506.www.knmg.nl2320
507.www.medicalistes.org2290
508.www.cegedim.fr2270
509.www.asmn.re.it2270
510.www.avandia.com2270
511.www.asf.toscana.it2260
512.www.uzgent.be2260
513.www.doktor-turk.net2260
514.www.ausl.pe.it2220
515.www.gaslini.org2220
516.www.kib.ki.se2210
517.www.hno.org2200
518.www.ieo.it2180
519.www.dtg.mwn.de2150
520.www.rdgg.nl2150
521.www.forensischepsychiatrie.nl2140
522.www.sesam-vitale.fr2100
523.www.sirm.org2090
524.www.siapec.it2070
525.www.policlinico.mi.it2070
526.www.nvkc.nl2070
527.www.ks.se2070
528.www.sfpediatrie.com2060
529.www.sism.org2060
530.www.allerg.qc.ca2040
531.www.uza.be2040
532.neurologia.rediris.es2020
533.www.gpini.it2010
534.www.advair.com2010
535.www.aging.it2000
536.www.emedea.it2000
537.www.medix.free.fr1990
538.www.em.mpg.de1970
539.www.medicina.it1970
540.www.psiquiatria.org.co1950
541.www.necker.fr1920
542.www.auditio.com1920
543.www.forensik.de1910
544.www.neuro.it1910
545.www.euro-emergencymed.com1900
546.www.pediadol.org1880
547.www.biomedia.net1880
548.www.tupediatra.com1870
549.www.maartenskliniek.nl1870
550.www.neuro.mpg.de1850
Pages:  1  2  3  4  5  6  7  8  9  10  11  12 
 13  14  15  16 



Subscribe to RSS feed Subscribe to Feed Burner feed Add to Del.icio.us Add to Yahoo Add to Google Add to Reddit Add to Blink Add to Meneame Add to Fark Add to Newsvine

502. neuroscript.com

Rating: 2360 points*
*amount mentions of word 'neuroscript.com' on the other websites

neuroscript.com

www.neuroscript.com

Description: Neurologische Fachinformation als Skriptum - Arztinfo, keine Laieninfo

Google

© 2005-2012 www.Top100Medicine.com
Couple's Gift for Mental Health
Former art collectors Barbara and Donald Jonas donated $500,000 to the New York-Presbyterian Hospital to help provide mental-health services to non-psychiatric patients.
online.wsj.com
FDA Panel Recommends Novartis MS Drug
The Burrill Report submits: By Michael Fitzhugh A Food and Drug Administration panel has unanimously backed the safety and effectiveness of Novartis' (NVS) multiple sclerosis treatment fingolimod. The panel voted 25-0 in support of fingolimod's “substantial evidence of effectiveness” in treating patients with relapsing remitting multiple sclerosis. That makes it likely the drug will be the first oral MS treatment to gain FDA approval, beating Merck (MRK), Sanofi (SNY) and Teva (TEVA) - all of which are developing their own oral MS drugs - to the punch.Complete Story »
seekingalpha.com
Axial Capital Again Adds to QLT Stake
Market Folly submits:Just a few days ago we detailed how Eliav Assouline and Marc Andersen's hedge fund Axial Capital was buying shares of QLT Inc (QLTI). This trend continues as Axial recently filed another Form 4 with the SEC regarding QLTI shares. On July 6th, 2010, Axial purchased 109,157 shares of QLT Inc. at a price of $5.79 per share. This brings their total ownership up to 6,304,586 shares. Eliav and Andersen's hedge fund has been accumulating shares over the span of a few months now, continuing to buy as QLTI trades lower.The interesting thing with this play is that many have characterized QLT Inc as a value trap or a 'cigarette-butt' type of investment. It is essentially a play on the biotech company's royalty stream. Some argue that while the stream is healthy now, it is likely to decline. Assouline and Andersen seem to disagree as they continue to accumulate shares.Complete Story »
seekingalpha.com
BioMarin Pipeline Update
Zacks.com submits: Recently, BioMarin Pharmaceutical Inc.’s (BMRN) pipeline received a boost with the US Food and Drug Administration (FDA) granting orphan drug status to its candidate BMN-701, which is being developed to combat Pompe disease. The investigational new drug (IND) application for the candidate, which has been effective in pre-clinical studies, was accepted by the FDA with clinical trials expected to commence in the first quarter of 2011.Complete Story »
seekingalpha.com
PPD Announces Third Quarter 2010 Earnings Release, Webcast and Conference Call
[Business Wire] - WILMINGTON, N.C.----PPD, Inc. will release its third quarter 2010 financial results on Tuesday, October 26, 2010, after the market closes. The earnings release will be available on the PPD website at www.ppdi.com.
us.rd.yahoo.com